Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01741727
Title A Study of ABT-414 in Subjects With Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie (prior sponsor, Abbott)

Advanced Solid Tumor

lung squamous cell carcinoma


Depatuxizumab mafodotin

Age Groups: adult
Covered Countries USA | CAN

No variant requirements are available.